Skip to content

Effect of Unani Drug gulnar in reduction of Vaginal discharge due to Bacterial infection.

Effect of Gulnar (Punica granatum L. Flower) in Bacterial Vaginosis: A Randomized Placebo Controlled Trial. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101383
Enrollment
44
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

Intervention1: Gulnar (Flower of Punica granatum): Method of Sitz bath The test group will receive a sitz bath prepared with flowers of Punica granatum Gulnar Approximately 14 grams of Punica grana

Sponsors

Luqman Unani Medical College Hospital and Research Centre 12 Naubag Vijaypur Karnataka 586101
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria Married women between 18 and 45 years of with complaints of abnormal vaginal discharge Associated with without lower backache lower abdomen pain dysuria dyspareunia vulvar irritation Participants with any 3 of Amsels criteria Vaginal pH more than 4.5 Positive whiff test Presence of clue cells Per speculum Homogenous white discharge

Exclusion criteria

Exclusion criteria: Exclusion criteria Pregnant lactating and menopausal women Recent use of systemic or local antibiotics in the past 2 weeks Patients with systemic and metabolic diseases Patients on oral contraceptive pills Patients with PID cervicitis

Design outcomes

Primary

MeasureTime frame
Primary outcome measures Change in clinical feature. Negative whiff test normal vaginal discharge and in saline test of vaginal wet mount less than 20% clue cells on microscopic examination. Timepoint: Primary outcome will be assessed at 0th day 15th and post treatment after 1 month.

Secondary

MeasureTime frame
Secondary outcome measures Improvement in quality of life assessed by SF-12 scoreTimepoint: Secondary outcome will be assessed at baseline and post treatment follow-up on 15th day

Countries

India

Contacts

Public ContactDR Khalil Ahmed

Luqman Unani Medical College Hospital and Research Centre 12 Naubag Vijayapura Karnataka 586101

nikhatinamdar72@gmail.com07795447144

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026